Categories
CDE Diabetes

Study Guide: FIT Recommendations for Best Practice in Injection Technique

1. Core Concepts & Goals

  • Objective: To ensure the correct dose of medication is delivered to the correct injection site using proper technique to achieve optimal health outcomes.

  • Golden Rule: Insulin and GLP-1 receptor agonists should be injected into the subcutaneous tissue (fat), avoiding intramuscular (IM) injection.

  • Primary Complication: Lipohypertrophy (rubbery lesions) is the most common complication and leads to glycemic variability and unexplained hypoglycemia.

2. Device Selection & Needle Length

Pen Needles vs. Syringes

  • Needle Length Standard: 4-mm pen needles are suitable for all patients regardless of BMI (Body Mass Index).

    • They reduce the risk of intramuscular (IM) injection compared to longer needles.

    • They provide equivalent glycemic control to 8-mm or 12-mm needles even in patients with obesity.

  • Syringes: The shortest available syringe needle is currently 6-mm.

  • Not Recommended: 12-mm or 12.7-mm needles are generally not recommended due to high IM risk.

Safety & Hygiene

  • Single Use Only: Needles and syringes should be used once and disposed of immediately.

  • Consequences of Reuse: Needle breakage, clogging, inaccurate dosing, and lipohypertrophy.

  • Disposal: Use approved sharps containers; never resheathe (recap) needles.

3. Injection Technique

Preparation

  • Hand Washing: Always wash hands with soap and water; disinfect injection site if required (e.g., hospital setting) but let alcohol dry completely.

  • Cloudy Insulin (NPH/Premix): Gently roll 10 times and tip 10 times until milky white. Do not shake.

  • Priming: Always prime the pen (air shot) to ensure flow. Note: GLP-1 pens may only need priming once per first use (check manufacturer).

Insertion & Angle

  • 4-mm Needles: Inject at a 90-degree angle. A skin lift (pinch-up) is generally not required for adults but may be needed for very lean limbs/abdomens.

  • 6-mm Syringes/Needles:

    • 90-degree into a skin lift.

    • 45-degree may be required for lean individuals if no skin lift is used.

  • 8-mm Needles: Must use a skin lift and inject at 90 degrees. Lean patients should use a 45-degree angle with a skin lift.

The “Skin Lift” (Pinch-up)

  • Method: Lift skin and subcutaneous tissue delicately between thumb and index finger.

  • Avoid: Do not lift muscle. Do not squeeze so hard it causes blanching or pain.

Dwell Time

  • Count to 10: After the dose knob is fully depressed, hold the needle in place for a slow count of 10 seconds to ensure full dose delivery and prevent leakage.

4. Injection Sites & Rotation

Site Selection

  • Preferred Site: The abdomen is preferred for consistent absorption, especially for soluble (Regular) and NPH insulin.

  • Other Sites: Thighs (upper third anterior lateral) and Buttocks (posterior lateral upper).

  • The Arm: The arm is not a preferred site for self-injection due to difficulty ensuring a 90-degree angle and high risk of IM injection into the deltoid.

  • Avoid: Umbilicus (stay 2-3 cm away), moles, scars, and lipohypertrophy.

Rotation Strategy

  • Systematic Rotation: Essential to prevent lipohypertrophy.

  • Spacing: Injections should be spaced at least 1 to 2 cm (one finger width) apart.

  • Plan: Rotate sites within the same anatomical area (e.g., abdomen) at the same time of day to reduce glycemic variability.

5. Complications: Lipohypertrophy

  • Definition: “Rubbery” or thickened lesions in the fat tissue caused by insulin’s anabolic effect and needle reuse/lack of rotation.

  • Consequences:

    • erratic/blunted absorption (insulin pooling).

    • Unexplained hypoglycemia or hyperglycemia.

    • Increased insulin requirements (higher doses needed).

  • Detection: Visual inspection and palpation (sweeping motion with fingertips).

  • Management: Stop injecting into the area immediately. Use a new needle every time. Rotate sites.

    • Clinical Pearl: When switching from a lipo (rubbery) site to healthy tissue, reduce the insulin dose (often by ~20%) to prevent hypoglycemia, as absorption will suddenly improve.

6. Special Populations

Pregnancy

  • Preferred Site: Abdomen.

  • Third Trimester: Use the lateral sides of the abdomen (flanks) as the central skin becomes taut.

  • Needle: Use 4-mm needles to avoid fetal harm or IM injection.

Pediatrics

  • Needles: 4-mm is the safest length.

  • Technique:

    • Children >6 years: 4-mm at 90 degrees (no pinch usually needed).

    • Children 2-6 years: 4-mm with a skin lift.

  • Sites: Buttocks may be better for preschool children due to more fat tissue.

Older Adults

  • Considerations: Thinner skin, reduced dexterity, cognitive changes.

  • Device: Pens are preferred over syringes for safety and ease of use.

  • Cognitive Assessment: Use the Clock Drawing Test to assess ability to manage injection therapy.

7. Insulin Infusion (Pumps)

  • Change Frequency: Infusion sets should be changed every 2 to 3 days to prevent infection and lipohypertrophy.

  • Cannula Selection:

    • Teflon: Flexible, comfortable. Change every 2-3 days.

    • Steel: For those with Teflon allergies or kinking issues (e.g., pregnancy, high muscle mass). Change every 2 days.

  • Troubleshooting: “Unexplained hyperglycemia” = Check for occlusion/kinking. If ketones present, give insulin via pen/syringe immediately.

8. Storage & Handling

  • In-Use Insulin: Store at room temperature (max 25-30°C) to reduce injection pain and air bubbles.

    • Usually good for ~28 days (check manufacturer).

  • Unopened Insulin: Refrigerator (2 to 8°C). Do not freeze.

  • Extreme Temps: Avoid direct sunlight or temperatures >30°C.

Reference:

Berard L, Desrochers F, Husband A, MacNeil G, Roscoe R. FIT Canada Recommendations for Best Practice in Injection Technique – 4th Edition. Accessed June 8, 2025. http://www.fit4diabetes.com/canada-english/